Effects of serelaxin in patients admitted for acute heart failure: a meta‐analysis-Reference-Cited by-同舟云学术

Effects of serelaxin in patients admitted for acute heart failure: a meta‐analysis

Published:2020-02 Issue:2 Volume:22 Page:315-329
ISSN:1388-9842
Container-title:European Journal of Heart Failure
language:en
Short-container-title:Eur J Heart Fail

Author:

Teerlink John R.¹,Davison Beth A.²,Cotter Gad²,Maggioni Aldo P.³,Sato Naoki⁴,Chioncel Ovidiu⁵,Ertl Georg⁶,Felker G. Michael⁷,Filippatos Gerasimos⁸,Greenberg Barry H.⁹,Pang Peter S.¹⁰,Ponikowski Piotr¹¹,Edwards Christopher²,Senger Stefanie²,Teichman Sam L.¹²,Nielsen Olav Wendelboe¹³,Voors Adriaan A.¹⁴,Metra Marco¹⁵

Affiliation:

1. Section of Cardiology, San Francisco Veterans Affairs Medical Center and School of MedicineUniversity of California San Francisco San Francisco CA USA

2. Momentum Research, Inc. Durham NC USA

3. Italian Association of Hospital Cardiologists (ANMCO) Research Center Florence Italy

4. Cardiology and Intensive Care UnitNippon Medical School, Musashi‐Kosugi Hospital Kawasaki Japan

5. University of Medicine Carol Davila Bucharest Romania

6. Julius‐Maximilians‐Universität Würzburg Würzburg Germany

7. Division of CardiologyDuke University School of Medicine Durham NC USA

8. Athens University Hospital Attikon Athens Greece

9. Division of CardiologyUniversity of California San Diego CA USA

10. Department of Emergency MedicineIndiana University School of Medicine Indianapolis IN USA

11. Department of Heart DiseasesMedical University, Military Hospital Wroclaw Poland

12. Formerly Corthera San Carlos CA USA

13. Department of CardiologyBispebjerg Hospital, University of Copenhagen Copenhagen Denmark

14. University Medical Center Groningen Groningen The Netherlands

15. Department of Medical and Surgical Specialties, Radiological Sciences, and Public HealthUniversity of Brescia Brescia Italy

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ejhf.1692

Reference30 articles.

1. Diuretic Strategies in Patients with Acute Decompensated Heart Failure

2. Short-term Clinical Effects of Tolvaptan, an Oral Vasopressin Antagonist, in Patients Hospitalized for Heart FailureThe EVEREST Clinical Status Trials

3. RELAX-AHF, BLAST-AHF, TRUE-AHF, and other important truths in acute heart failure research

4. A randomized, double-blind, placebo-controlled, multicentre study to assess haemodynamic effects of serelaxin in patients with acute heart failure

5. Effect of Serelaxin on Cardiac, Renal, and Hepatic Biomarkers in the Relaxin in Acute Heart Failure (RELAX-AHF) Development Program

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic impact of acute decompensated heart failure in patients with heart failure with mildly reduced ejection fraction;European Heart Journal: Acute Cardiovascular Care;2023-11-10

2. The prognostic value of systemic vascular resistance in heart failure patients with permanent atrial fibrillation: a retrospective study;Heart and Vessels;2023-09-25

3. Cardiovascular effects of relaxin-2: therapeutic potential and future perspectives;Clinical Research in Cardiology;2023-09-18

4. Acute Heart Failure: Diagnostic–Therapeutic Pathways and Preventive Strategies—A Real-World Clinician’s Guide;Journal of Clinical Medicine;2023-01-20

5. Relaxin-2 plasma levels in atrial fibrillation are linked to inflammation and oxidative stress markers;Scientific Reports;2022-12-24